North America Healthcare Bioconvergence Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Healthcare Bioconvergence Market, by Application
1.4.2 North America Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Healthcare Bioconvergence Market by Application
3.1 North America Drug Discovery Market by Country
3.2 North America Precision Medicine Market by Country
3.3 North America Regenerative Medicine Market by Country
3.4 North America Diagnostic & Biological Sensors Market by Country
3.5 North America Bioelectronics Market by Country
3.6 North America Nanorobotics for Drug Delivery Market by Country
3.7 North America Engineered Living Materials Market by Country
3.8 North America Optogenetics Market by Country

Chapter 4. North America Healthcare Bioconvergence Market by Country
4.1 US Healthcare Bioconvergence Market
4.1.1 US Healthcare Bioconvergence Market by Application
4.2 Canada Healthcare Bioconvergence Market
4.2.1 Canada Healthcare Bioconvergence Market by Application
4.3 Mexico Healthcare Bioconvergence Market
4.3.1 Mexico Healthcare Bioconvergence Market by Application
4.4 Rest of North America Healthcare Bioconvergence Market
4.4.1 Rest of North America Healthcare Bioconvergence Market by Application

Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview